Here's the Biotech Pfizer Should Consider Acquiring Next

[cafead]

via

• Pfizer plans to develop future mRNA vaccines and therapies on its own without BioNTech.
• Acquiring a small biotech with mRNA expertise could help Pfizer achieve its goals.
• There's one such biotech that also would give it two promising immunotherapy candidates and a solid platform for developing vaccines and immunotherapies targeting a wide range of diseases.

article source